<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9"
        xmlns:news="http://www.google.com/schemas/sitemap-news/0.9">
  <url>
    <loc>https://biotechmorning.com/news/pelacarsen-lpa-horizon-trial-failure</loc>
    <news:news>
      <news:publication>
        <news:name>Biotech Morning</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-09-06T14:14:34.575Z</news:publication_date>
      <news:title>The Drug That Crushed a Risk Factor But Couldn&apos;t Save a Single Heart</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://biotechmorning.com/news/teva-celiac-disease-phase-2-first-drug</loc>
    <news:news>
      <news:publication>
        <news:name>Biotech Morning</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-09-06T14:13:45.229Z</news:publication_date>
      <news:title>The First Drug That Might Let Celiac Patients Eat a Breadstick</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://biotechmorning.com/news/invivyd-board-chair-ceo-clinical-readout</loc>
    <news:news>
      <news:publication>
        <news:name>Biotech Morning</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-09-06T14:12:57.386Z</news:publication_date>
      <news:title>Invivyd&apos;s Board Chair Just Took the Wheel. The Timing Is Everything.</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://biotechmorning.com/news/novartis-kleinbasel-biologics-site-closure</loc>
    <news:news>
      <news:publication>
        <news:name>Biotech Morning</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-09-06T14:12:11.048Z</news:publication_date>
      <news:title>Novartis Is Shrinking in Switzerland to Get Bigger Everywhere Else</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://biotechmorning.com/news/treprostinil-ipf-teton-phase-3-results</loc>
    <news:news>
      <news:publication>
        <news:name>Biotech Morning</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-09-06T14:11:30.475Z</news:publication_date>
      <news:title>A Blood Pressure Drug Just Slowed Lung Scarring. Wait, What?</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://biotechmorning.com/news/lilly-zepbound-cheaper-vials-higher-doses</loc>
    <news:news>
      <news:publication>
        <news:name>Biotech Morning</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-09-06T14:10:49.227Z</news:publication_date>
      <news:title>Lilly Just Made Its Blockbuster Weight-Loss Drug a Lot Cheaper to Get</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://biotechmorning.com/news/sangamo-gene-therapy-fire-sale-ptc-lilly</loc>
    <news:news>
      <news:publication>
        <news:name>Biotech Morning</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-09-05T14:14:42.926Z</news:publication_date>
      <news:title>The $161M Fire Sale That Ended a Gene Therapy Pioneer</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://biotechmorning.com/news/autoimmune-car-t-safety-problem</loc>
    <news:news>
      <news:publication>
        <news:name>Biotech Morning</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-09-05T14:13:57.273Z</news:publication_date>
      <news:title>Autoimmune CAR-T Has a Problem Nobody Wants to Talk About</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://biotechmorning.com/news/pelacarsen-lp-a-horizon-trial-failure</loc>
    <news:news>
      <news:publication>
        <news:name>Biotech Morning</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-09-05T14:13:12.027Z</news:publication_date>
      <news:title>The Biggest Heart Drug Bet in a Decade Just Went Bust</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://biotechmorning.com/news/pfizer-penicillin-recall-syphilis-crisis-2</loc>
    <news:news>
      <news:publication>
        <news:name>Biotech Morning</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-09-05T14:12:21.405Z</news:publication_date>
      <news:title>America&apos;s Only Syphilis Drug for Pregnant Women Just Got Recalled</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://biotechmorning.com/news/menarini-gan-lee-glp1-licensing-deal-europe</loc>
    <news:news>
      <news:publication>
        <news:name>Biotech Morning</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-09-05T14:11:40.922Z</news:publication_date>
      <news:title>Italy&apos;s Biggest GLP-1 Bet Came From a Company You&apos;ve Never Heard Of</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://biotechmorning.com/news/sarepta-black-box-layoffs-stock-rally</loc>
    <news:news>
      <news:publication>
        <news:name>Biotech Morning</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-09-05T14:10:52.720Z</news:publication_date>
      <news:title>Sarepta&apos;s Worst Week: A Black Box, 500 Pink Slips, and a 33% Stock Rally</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://biotechmorning.com/news/blood-test-changed-breast-cancer-treatment</loc>
    <news:news>
      <news:publication>
        <news:name>Biotech Morning</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-09-05T14:10:06.062Z</news:publication_date>
      <news:title>A Blood Test Just Changed How We Treat Breast Cancer</news:title>
    </news:news>
  </url>
</urlset>